These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30731393)

  • 1. Development and characterization of benznidazole nano- and microparticles: A new tool for pediatric treatment of Chagas disease?
    Seremeta KP; Arrúa EC; Okulik NB; Salomon CJ
    Colloids Surf B Biointerfaces; 2019 May; 177():169-177. PubMed ID: 30731393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benznidazole microcrystal preparation by solvent change precipitation and in vivo evaluation in the treatment of Chagas disease.
    Maximiano FP; de Paula LM; Figueiredo VP; de Andrade IM; Talvani A; Sá-Barreto LC; Bahia MT; Cunha-Filho MS
    Eur J Pharm Biopharm; 2011 Aug; 78(3):377-84. PubMed ID: 21397015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM; Nadvorny D; Vieira ACQM; Schver GCRM; Soares Sobrinho JL; Rolim Neto PJ; Lee PI; Soares MFR
    Eur J Pharm Sci; 2018 Jul; 119():208-218. PubMed ID: 29679707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
    de Moura Ferraz LR; Tabosa AÉGA; da Silva Nascimento DDS; Ferreira AS; Silva JYR; Junior SA; Rolim LA; Rolim-Neto PJ
    J Mater Sci Mater Med; 2021 May; 32(6):59. PubMed ID: 33999312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
    Palmeiro-Roldán R; Fonseca-Berzal C; Gómez-Barrio A; Arán VJ; Escario JA; Torrado-Durán S; Torrado-Santiago S
    Int J Pharm; 2014 Sep; 472(1-2):110-7. PubMed ID: 24928135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
    Fonseca-Berzal C; Palmeiro-Roldán R; Escario JA; Torrado S; Arán VJ; Torrado-Santiago S; Gómez-Barrio A
    Exp Parasitol; 2015 Feb; 149():84-91. PubMed ID: 25583295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
    Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D; Salomón CJ; Lamas MC; Olivieri AC
    Int J Pharm; 2009 Feb; 367(1-2):140-7. PubMed ID: 18938233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methacrylate micro/nano particles prepared by spray drying: a preliminary in vitro/in vivo study.
    Muñoz Ortega B; Sallam MA; Marín Boscá MT
    Drug Deliv; 2016 Sep; 23(7):2439-2444. PubMed ID: 25715809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease.
    Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
    Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
    Scalise ML; Arrúa EC; Rial MS; Esteva MI; Salomon CJ; Fichera LE
    Am J Trop Med Hyg; 2016 Aug; 95(2):388-93. PubMed ID: 27246447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.
    Homayouni A; Sadeghi F; Varshosaz J; Garekani HA; Nokhodchi A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
    García MC; Manzo RH; Jimenez-Kairuz AF
    Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
    Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
    Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the oral delivery of benznidazole nanoparticles by optimizing the formulation parameters through a design of experiment and optimization strategy.
    Arrua EC; Hartwig O; Loretz B; Goicoechea H; Murgia X; Lehr CM; Salomon CJ
    Colloids Surf B Biointerfaces; 2022 Sep; 217():112678. PubMed ID: 35816885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Prototype Device for Microencapsulation of Benznidazole: In Vitro/In Vivo Studies.
    Barrera MG; Tejada G; Leonardi D; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2020 Mar; 21(3):112. PubMed ID: 32236813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-Assembled Benznidazole-Loaded Cationic Nanoparticles Containing Cholesterol/Sialic Acid: Physicochemical Properties, In Vitro Drug Release and In Vitro Anticancer Efficacy.
    Dos Santos-Silva AM; de Caland LB; do Nascimento EG; Oliveira ALCSL; de Araújo-Júnior RF; Cornélio AM; Fernandes-Pedrosa MF; da Silva-Júnior AA
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan based micro- and nanoparticles for colon-targeted delivery of vancomycin prepared by alternative processing methods.
    Cerchiara T; Abruzzo A; di Cagno M; Bigucci F; Bauer-Brandl A; Parolin C; Vitali B; Gallucci MC; Luppi B
    Eur J Pharm Biopharm; 2015 May; 92():112-9. PubMed ID: 25769679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
    Wang T; Xue J; Hu Q; Zhou M; Luo Y
    J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.